[Drug-induced enterocolitis].
Van Gossum
A
A
Michils
A
A
Madhoun
P
P
Lecocq
E
E
D000925:Anticoagulants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D004760:Enterocolitis / Q000139:chemically induced*; D004876:Ergot Alkaloids / Q000009:adverse effects; D006046:Gold / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008750:Methyldopa / Q000009:adverse effects; D012460:Sulfasalazine / Q000009:adverse effects
D000925:Anticoagulants; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D003276:Contraceptives, Oral; D004876:Ergot Alkaloids; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D008750:Methyldopa; D006046:Gold
Les entérocolites médicamenteuses.